Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Express Scripts (ESRX)

Express Scripts (ESRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Express Scripts ONE EXPRESS WAY SAINT LOUIS MO 63121 USA

www.express-scripts.com P: 314-996-0900

Description:

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Key Statistics

Overview:

Market Capitalization, $K 52,061,192
Shares Outstanding, K 563,860
Annual Sales, $ 100,065 M
Annual Net Income, $ 4,517 M
Last Quarter Sales, $ 25,563 M
Last Quarter Net Income, $ 1,072 M
60-Month Beta 0.88
% of Insider Shareholders 0.79%
% of Institutional Shareholders 84.87%

Growth:

1-Year Return 24.79%
3-Year Return 4.62%
5-Year Return 30.78%
5-Year Revenue Growth 6.61%
5-Year Earnings Growth 89.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.43 on 10/31/18
Latest Earnings Date N/A
Earnings Per Share ttm 8.58
EPS Growth vs. Prev Qtr 9.46%
EPS Growth vs. Prev Year 27.89%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 06/08/10

ESRX Ratios

Ratio
Price/Earnings ttm 11.17
Price/Earnings forward 10.16
Price/Earnings to Growth 1.16
Return-on-Equity % 25.43%
Return-on-Assets % 8.94%
Profit Margin % 4.51%
Debt/Equity 0.83
Price/Sales 0.54
Price/Cash Flow 8.80
Price/Book 2.53
Book Value/Share 36.49
Interest Coverage 9.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar